Bibliografía.

1.Anatomiamedia type="custom" key="18412390" align="right"
 * 1.1 LIPERT. H, Anatomia con orientacion clinica 2006, capitulo 7: cabeza y cuello, 7.4 faringe y sus derivados, #746 Glandula Tiroides, pg 581-585
 * 1.2 ADAM. Enciclopedia Multimedia. Tirodoctomia- serie
 * 1.3 []
 * 1.4 []

2.Histologia
 * 2.1 ROSS.M, Histologia texto y atlas color con biologia celular y molecular 5ta edicion, capitulo 21: Sistema endocrino, Glandula Tiroides, pg 753-758
 * 2.2 HERNANDEZ.H, Youtube: Histologia-Tiroides,29/06/2011.
 * 2.3 Imagenes tomadas de la guia practica de la catedra de histologia, tema: Glandula Tiroides
 * 2.4 RONDONDI.N, Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
 * 2.5 []

3. Integrantes -UCV
 * 3.1 Edición y video: PAIVA.Y. Fotógrafos: ZARATE.A, GALAVIS.E, SALAS.K, CARRERA.G, VIAÑA.M, URBANI.S, DIAZ.Y.Youtube: Ciudad Universitaria de Caracas. 12/04/2011
 * 3.2 GUEVARA.L, La Manzana Producciones,Youtube: La Universidad es tuya. 20104
 * 3.3 Universidad Central de Venezuela. Sobre La UCV. Galeria de Imagenes UCV. [|www.ucv.ve]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">3.4. Universidad Central de Venezuela. Sobre La UCV. Reseña Historial. [|www.ucv.ve]

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">4.Embriologia
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">4.1 ROSS.M, Histologia texto y atlas color con biologia celular y molecular 5ta edicion, capitulo 21: Sistema endocrino, Glandula Tiroides, pg 753-758
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">4.2 Imagenes obtenidas del programa academico de Embriologia. []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.Hormonas Tiroideas
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.1 LEOHHDEZ. H, Animacion de Mc Graw Hill, Youtube: mecanismo de accion de la tiroxina, 28/05/2010.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.3 LEOHHDEZ. H, Animacion de Mc Graw Hill, Youtube: Regulacion y Funcion de las hormonas Tiroideas, 28-05-2010
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.4 Guía de Seguimiento Farmacoterapéuticoen Hipotiroidismo e Hipertiroidismo,[]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.5 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.6 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.7 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.8 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.9 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.10 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.11 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.12 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.13 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">5.14 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.Curiosidades <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">-Hipertiroidismo y riesgo cerebrovascular
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.1 LIN.Herng-Ching, El hipertiroidismo aumenta el riesgo de accidente cardiovascular, Revista Stroke de la Universidad Médica de Taipei, Taiwán.09-04-2012.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.2 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">-Tiroidectomía.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.3 ASTINI.C,GUARINO.S,SHEERAYE.M, Hospital de Balbala, Youtube: Total thyroidectomy, 16-06-2011
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.4[]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.5[]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.9 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.10 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.11 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.12[]

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">- Carnitina:
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.4 Beta-oxidación - Guía metabólica[| http://www.guiametabolica.org/category/tags/beta-oxidacion]

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">-Exploración Física de la Tiroides.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.6 ETINEO. Youtube; Exploracion Fisica parte 6: Cuello.12-12-2008
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">6.7 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">7. Caso Clinico <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">-Presentacion del Caso
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">7.1 SALCEDO. Q, GoAnimated: wik, 16-05-2012
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">7.8 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">-Estado Nutricional


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">7.2 COMITÉ DE EXPERTOS DE LA O.M.S SOBRE EL ESTADO FÍSICO- El Estado Físico: Uso e Interpretación de la Antropometría. OMS, Serie de Informes Técnicos, 854. Ginebra: 1993; pag. 429. Disponible Online en la dirección web:http://whqlibdoc.who.int/trs/WHO_TRS_854_spa.pdf; consultado el 17/05/2012 a las 15:30.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">7.3 BICKSTON, S. Terapia Nutricional. En: FOSTER, C; MISTRY, N; PEDDI, P; SHARMA, S.Manual Washington de Terapéutica Médica, 28ª Edición. Lippincott Williams & Wilkins, 2005. Pag. 36.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">7.4 Tabla disponible en la dirección web: http://es.wikipedia.org/wiki/%C3%8Dndice_de_masa_corporal; basada en el gráfico disponible en la dirección de la O.M.S:http://www.euro.who.int/en/what-we-do/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi. Ambas consultadas el 17/05/2012 a las 22:00 y 22:05, respectivamente.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">7.5 GIL HERNÁNDEZ, A. Tratado de Nutrición: Nutrición Clínica, Tomo IV. Editorial Médica Panamericana, 2010. Pp. 36-37
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">7.6 http://www.saludybienestar.cl/?p=385
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">7.7 http://www.recetasgratis.net/Receta-de-Ensalada-lechuga-receta-38208.html
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">7.9 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">8. Hipertiroidismo
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">8.1 []
 * 8.2-Estadísticas del hipertiroidismo. Visitado online el 16/05/2012 en: [|www.tiroides/revista/consenso.ht]
 * 8.3 Harrison Principios de Medicina Interna 17va edición (2006). « [|Capítulo 335. Trastornos de la glándula tiroides] » (en español) .//Harrison online en español//. [|McGraw-Hill] . Consultado el 18 de mayo de 2012

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">-sintomas > <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">9.Lipolisis
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">8.4 http://www.umm.edu/graphics/images/es/14060.jpg <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">9.1 AVAREZ.D. Estudio de imagenes de Histologia. slideshare.net
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">9.2 SANDER.J.(1997). Management of lipid disorders. A basis and guide for therapeutic intervention. Ed. Henry Ling Ltd. The Dorset Press, Dorchester, G.B., U.K.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">9.3 [|www.themedicalchemistrypage.org]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">9.4 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">10.Insulina y cascada PI-3K


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">10.1 DIAZ. K. Catedra de Bioquimica- UCV. Transduccion de señales. Marzo, 2011
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">10.2 SUAREZ. D, SUAREZ. J. Youtube: Cascada de la Insulina.Bioquimica. 13-06-2009
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">10.3 MCPPHEE. S.J, HAMMER. G.D, Fisiopatologia de la enfermedad: Una introduccion a la medicina clinica. 6ta edicion. Capitulo 18: Transtornos del pancreas endocrino. Fisiologia. 1. Insulina. Pg: 498-500.

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">11.Glucagon y casacda AMPc

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12. Enfermedad de Graves
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">11.1 DIAZ. K. Catedra de Bioquimica- UCV. Transduccion de señales. Marzo, 2011
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">11.2 SUAREZ.D, Youtube: Cascada del AMPC con la hormona glucagon!. 12-06-2009
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">11.3 MCPPHEE. S.J, HAMMER. G.D, Fisiopatologia de la enfermedad: Una introduccion a la medicina clinica. 6ta edicion. Capitulo 18: Transtornos del pancreas endocrino. Fisiologia. 2.Glucagon. Pg: 501-502
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">11.4 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">-Enfermedad de Graves


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.1MCPPHEE. S.J, HAMMER. G.D, Fisiopatologia de la enfermedad: Una introduccion a la medicina clinica. 6ta edicion. Capitulo 20: Enfermedad Tiroidea. Enfermedad de Graves. Pag: 555-559
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.2 CCM. Centro cardiometabolico.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.3 RIZZO L, NIEPOMNISZCZE H. El paciente con patología tiroidea. En: Programa de Actualización en Medicina Interna (PROAMI), fascículo 2, 2º ciclo (Lasala FG, ed), Buenos Aires: Panamericana 1997. Pag 99.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.4 ROSS, D. Overview of the clinical manifestations of hyperthyroidism. En: UpTo-Date Rose BD Ediciones,USA, 2007. Pag. 26.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.5 NAYAK, S. Hyperthyroidism. Endocr Metab Clin N Am 36,USA, 2007. Pag: 638

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">-Genetica Asociada
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.6 BAHN, R. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves’ ophthalmopathy (Review). J Endocrinol Invest 27, 2004.Pag.218.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.7 JACOBSON, E; TOMER, Y. The genetic basis of thyroid autoimmunity. Thyroid 17, 2007. Pag. 955.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.8 TAYLOR, J; GOUGH S; HUNT P.J; ET AL. A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab 91, 2006. Pag. 636


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.9 []

-Diagnostico Histologico


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.10 ANDERSON, S; MANDEL, S; LIVOLSI, V. ET AL. Can cytomorphology differentiate between benign nodules and tumors arising in Graves’ disease? Diagn Cytopathol: 31, 2004. Pag. 65.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.11 ALLANIC, H; FAUCHET, R; ORGIAZZI, J; ET AL. Antithyroid drugs and Graves’ disease: A prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab 70, 1990. Pag. 676.

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">-Diagnostico Etiologico


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.12 ENGLER, D; DONALDSON, EB, STOCKIGT, JR; TAFT, P: Hyperthyroidism without triiodothyronine excess: An effect of severe nonthyroidal illness. J Clin Endocrinol Metab 46:, 1978. Pp. 77-82
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.13GAUNA, A; SEGURA, G; SARTORIO, G; SOTO, R, SEGALl-EIRAS, A. Immunological aspects of Graves’ disease in different clinical stages. J Endocrinol Invest 12, 1989.Pag. 673.

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">-Diagnostico Diferencial


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.13 FELDT-RASMUSSEN, M. Anti-thyroid peroxidase antibodies in thyroid disorder and non thyroid autoimmune diseases. Autoimmunity 9,1991. Pag 247.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">12.14 REES-SMITH, B; SANDERS, J; FURMANIAK, J. TSH receptor antibodies. Thyroid 17:, 2007. Pp. 923-38.

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">13.Reesterificacion
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">13.1 Guia de metabolismo de lipidos de la catedra de bioquimica
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">13.2 ÁLVAREZ.J. Reesterificacion de Acidos grasos.http://bioquiwik1.wikispaces.com/Rutas+Metabolicas
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">13.3[|www.adam.com]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">14.4 CIDESA. centro integral de salud alimenticia. []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">14.Beta-Oxidacion
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">14.1 Guia de metabolismo de lipidos de la catedra de bioquimica.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">14.2[|www.ferato.com]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">14.3 BETANCOURT. L, Beta-oxidacion de acidos grasos http://bioquiwik1.wikispaces.com/Rutas+Metabolicas
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">14.4 BOLGSPOT. El bolg del Higado. Fisiologia del Higado

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">15. Cetogenesis


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">15.1 Guia de metabolismo de lipidos de la catedra de bioquimica.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">15.2 ARIAS. H, Cetogenesis y cetolisis. http://bioquiwik1.wikispaces.com/Rutas+Metabolicas
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">15.3 KAULITZKI. S.www.123rf.com
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">15.4[|www.rincondesalud.com]

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">16.Hormonas del Apetito


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">16.1 LICATA.M - zonadiet.com
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">16.2 ROSS. BUSCAR
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">16.3 BOEREE.J. Departamento de Psicología.Universidad de Shippensburg. El sistema nervioso emocional
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">16.4 [|www.ADAM.com]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">16.5 Definicion ABC. Definicion de Hormona
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">16.6 www.jetviajes.com
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">16.7 [|www.subeimagenes.com]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">16.8 www.blogspot.com
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">16.9 [|www.sanacionnatural.net]

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">17.Glucogenolisis


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">17.1 BAQUERO.O.Glucogenolisis. http://bioquiwik1.wikispaces.com/Rutas+Metabolicas
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">17.2[|www.elcuerpohumano.net]

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">18.Efecto de insulina en tejidos


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">18.1 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">18.2 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">18.3 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">18.4 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">18.5 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">19. Efecto del Glucagon en tejidos


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">19.1 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">19.2 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">19.3 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">19.4 [|www.adam.com]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">19.5[]

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">20.Metabolismo de la hormona tiroidea


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">20.1 HARPER.V. Manual de química fisiológica, 16ava edición. 1978. Mayes Editorial El Manual Moderno, S.A. Av. Sonora 206, México 11, D.F.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">20.2[]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">20.3 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">20.4 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">20.5 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">21. Neoglucogénesis


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">21.1[]

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">22.Resistencia a la Insulina


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">22.1 DRA. ALIZA. Vida y Salud. ¿Que es la resistencia a la insulina?
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">22.2[]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">22.3 Medwave. Año VI No. 6 Julio 2006

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">23.Ciclo de Cori


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">23.1 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">23.2 AGUILERA.R.Ciclo de Cori http://bioquiwik1.wikispaces.com/Rutas+Metabolicas

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">24. Drogas Antitiroideas


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">24.1 BURCH HB, WARTOFSKY L. Hyperthyroidism. En: Current Therapy in Endocrinology and Metabolism, 5th ed. CW Bardin Ediciones. Philadelphia, 1994. Pp 64-70.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">24.2 MAUGENDRE D, GATEL A, CAMPION L. Antithyroid drugs and Graves’ disease. Prospective randomised assessment of long-term treatment. Clin Endocrinol, vol. 50, 1999, pp. 127-32.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">24.3 ABRAHAM P, AVENELL A, PARK CM, WATSON WA, BEVAN J. A systematic review of drug therapy for Graves’ hyperthyroidism. Eur J Endocrinol Vol. 153, 2005: pp. 489-98.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">24.4 CODACCIONI JL, ORGIAZZI J, BLANC P, PUGEAT M, ROULIER R, CARAYON P. Lasting remissions in patients treated for Graves’ hyperthyroidism with propranolol alone: A pattern of spontaneous evolution of the disease. J Clin Endocrinol Metab Vol 67: 1988, pp. 656-62.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">24.5 BINDU, N, HODAK, S.P. Hyperthyroidism . Endocrinol Metab Clin North Am Vol 36: 2007, pp. 617-56.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">24.6 TOHGI, H; KONNO,S; TAMURA, K; KIMURA, B; KAWANO, K. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke Vol 23: 1992 pp. 1400–1403.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">24.7 LEVY, G; TSUCHIYA, T. Salicylate accumulation kinetics in man. New England Journal of Medicine 287 (9): 1972 pp. 430–432.
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">24.8 www.farmaplus.com.ve
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">24.9 propranolol-australia.net

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">25.Ciclo de la Urea


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">25.1 BETANCOURT. J.A. Ciclo de la Urea.http://bioquiwik1.wikispaces.com/Rutas+Metabolicas
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">25.2 Metabolismo del nitrógeno y Ciclo de la Urea. []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">25.3 Ciclo de la Urea []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">25.4 Bioquímica-2° Farmacia []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">25.5 Metabolismo de los aminoacidos 2012. Presentación Power point de la Catedra de Bioquimica de la Universidad Central de Venezuela, Escuela Razetti.

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">26. Riesgo Metabólico


 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">26.1. Grundy, S. Vigersky, R. The Hormone Foundation`s Patient Guide on Metabolic Risk: Primary PRevention on Cardiovascular Disease and Type 2 Diabetes. The Hormone Foundation`s Magazine, The Endocrine Society, USA, 2008. Disponible en: [] Consultado el 06/06/2012 a las 19:27.

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">27. Glosario
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">27.1 http://universomedico.com.mx/diccionario-medico/
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">27.2 [|http://es.wikipedia.org/wiki/Diccionario_de_la_lengua_española]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">27.3 http://www.diccionario-medico.com.ar/

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">28.Efecto de las Hormonas Tiroideas
 * 28.2 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">28.3 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">28.4 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">28.5 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">29Glicolisis
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">29.1 AREVALO. M.A. Glicolisis. http://bioquiwik1.wikispaces.com/Rutas+Metabolicas
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">29.2 http://gsdl.bvs.sld.cu/greenstone/collect/prelicin/index/assoc/HASHe70d.dir/fig20a08.png

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">30.Lipogénesis
 * 30.2 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">30.3 ANTONETI. M.C. Lipogenesis. http://bioquiwik1.wikispaces.com/Rutas+Metabolicas
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">30.4 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">31.Ciclo de krebs
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">31.1 Thomas M. Devlin. Bioquímica, libro de texto con aplicaciones clínicas 4ta edición. Editorial reverté . Barcelona-espanna 2008
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">31.2 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">31.3 [|www.mahara.com]

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">32 Efectos de un exceso de hormonas tiroideas
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">32.1 www.med.unne.edu.ar/catedras/bioquimica/pdf/tiroideas.pdf
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">32.2 www.nlm.nih.gov/medlineplus/spanish/ency/article/003684.htm
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">32.3 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">32.4 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">33 Glucogenogénesis
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">33.1 http://www.menudiet.es/assets/images/content/images/dieta-higado.jpg
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">33.2[]

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">34. hipertiroidismo y sistema cardiovascular
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">34.1 http://es.wikipedia.org/wiki/Hipertiroidismo
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">34.2 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">35. Tratamiento y riesgos
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">35.1 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">35.2 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">36.Con respecto a las hormonas tiroideas
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">36.1 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">36.2 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">36.3 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">36.4[]
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">36.5 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">36.6 []

<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">37.Valoración de niveles de TSH,T3 y T4
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">37.1 [] a las 11:54 am día 5/6/2012
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">37.2 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">37.3 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">37.4 []
 * <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 120%; text-align: justify;">37.5 []

38Cómo mimetizan el efecto de la adrenalina...
 * 38.1 Berne RM y Levy MN. Fisiologia 3era edicion. Madrid: Harcourt. Mosby; 2001
 * 38.2 Boron WF, Boulpaep EL. Medical Physiology. Updated edition. Filadelfia (EEUU): Elsevier Saunders. 2005
 * 38.3 Burkitt HG, Young B, Heath JW. Histología funcional Wheater 3era edicion Madrid: Churchill Livingstone; 1993
 * 38.4 Costanzo LS. Fisiologia 1era edicion Méjico: McGraw-Hill Interamericana; 2000
 * 38.5 Drake RL, Vogl W, Mitchell AWM. Gray Anatomia para estudiantes 1era edicion Madrid: Elsevier; 2005
 * 38.6 Fox SI. Fisiología Humana 7ma edicion Madrid: McGraw-Hill-Interamericana; 2003.
 * 38.7 Best-Taylor. Bases fisiológicas de la práctica médica. Bs.As Ed. Panamericana 11a. ed. 1986
 * 38.8[]
 * 38.9 []

39. Cascadas de señalización
 * 39.1 []
 * 39.2 []

40. Efecto en los tejidos >
 * 40.1 []
 * 40.2 http://corpoumano.wikispaces.com/El+p%C3%A1ncreas

media type="custom" key="19091506"
<span style="display: block; height: 1px; left: -40px; overflow-x: hidden; overflow-y: hidden; position: absolute; top: 2704px; width: 1px;">themedicalbiochemistrypage.org/es/nitrogen-metabolism-sp.php <span style="display: block; height: 1px; left: -40px; overflow-x: hidden; overflow-y: hidden; position: absolute; top: 5011px; width: 1px;"><span class="rg_ctlv">propranolol-australia.net